Tamoxifen improves cholinergically modulated cognitive performance in postmenopausal women

Neuropsychopharmacology

Volumn 38, Issue 13, 2013, Pages 2632-2643

  Newhouse, Paul ^a,b   Albert, Kimberly ^a   Astur, Robert ^c   Johnson, Julia ^d   Naylor, Magdalena ^b   Dumas, Julie ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CONNECTICUT   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

acetylcholine; cognition; mecamylamine; menopause; scopolamine; tamoxifen

Indexed keywords

APOLIPOPROTEIN E4; MECAMYLAMINE; PLACEBO; SCOPOLAMINE; TAMOXIFEN;

ARTICLE; ATTENTION; CHOLINERGIC STIMULATION; COGNITION; COGNITIVE DEFECT; EPISODIC MEMORY; GENOTYPE; HIPPOCAMPUS; LEARNING; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; SPATIAL BEHAVIOR; TREATMENT DURATION; VERBAL MEMORY;

AGED; ATTENTION; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; ESTROGEN ANTAGONISTS; FEMALE; HUMANS; MECAMYLAMINE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; POSTMENOPAUSE; PSYCHIATRIC STATUS RATING SCALES; SCOPOLAMINE HYDROBROMIDE; TAMOXIFEN; TIME FACTORS; VERBAL LEARNING;

EID: 84888013749     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.172     Document Type: Article

References (93)

1. Ahles TA, Saykin AJ, Noll WW, Furstenberg CT, Guerin S, Cole B et al(2003). The relationship of APOE genotype to neuro-psychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-Oncology 12: 612-619.
2. Astur RS, Ortiz ML, Sutherland RJ (1998). A characterization of performance by men and women in a virtual Morris water task: a large and reliable sex difference. Behav Brain Res 93: 185-190.
3. Astur RS, Taylor LB, Mamelak AN, Philpott L, Sutherland RJ (2002). Humans with hippocampus damage display severe spatial memory impairments in a virtual Morris water task. Behav Brain Res 132: 77-84.
4. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatr 4: 53-63.
5. Bi R, Foy MR, Vouimba RM, Thompson RF, Baudry M (2001). Cyclic changes in estradiol regulate synaptic plasticity through the MAP kinase pathway. Proc Natl Acad Sci USA 98: 13391-13395.
6. Brann DW, Dhandapani K, Wakade C, Mahesh VB, Khan MM (2007). Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications. Steroids 72: 381-405.
7. Breckenridge LM, Bruns GL, Todd BL, Feuerstein M (2012). Cognitive limitations associated with tamoxifen and aromatase inhibitors in employed breast cancer survivors. Psycho-Oncology 21: 43-53.
8. Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE (2003). The role of APOE-e4 in longitudinal cognitive decline: Ma-cArthur studies of successful aging. Neurology 60: 1077-1081.
9. Breuer B, Anderson R (2000). The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents. Women Health 31: 71-86.
10. Brinton RD (2002). Selective estrogen receptor modulators (SERM) for the brain: recent advances and remaining challenges for developing a NeuroSERM (TM). Drug Develop Res 56: 380-392.
11. Buschke H (1973). Selective reminding for analysis of memory and learning. J Verbal Learn Verbal Behav 12: 543-550.
12. Chen D, Chun-Fu W, Shi B, Xu Y (2002). Tamoxifen and toremifene impair retrieval, but not acquisition, of spatial information processing in mice. Pharmacol Biochem Behav 72: 417-421.
13. Ciriza I, Carrero P, Azcoitia I, Lundeen SG, Garcia-Segura LM (2004). Selective estrogen receptor modulators protect hippo-campal neurons from kainic acid excitotoxicity: differences with the effect of estradiol. J Neurobiol 61: 209-221.
14. Coker LH, Espeland MA, Rapp SR, Legault C, Resnick SM, Hogan P et al(2010). Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS). J Steroid Biochem Mol Biol 118: 304-310.
15. Collaborative GoHFiBC (1997). Breast cancer and hormone replacement-therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52, 705 women with breast cancers and 108, 411 women without breast cancer. Lancet 350: 1047-1059.
16. Cyr M, Ghribi O, Thibault C, Morissette M, Landry M, Di Paolo T (2001a). Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors. Brain Res Rev 37: 153-161.
17. Cyr M, Morissette M, Landry M, Di Paolo T (2001b). Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors. Neuroreport 12: 535-539.
18. Cyr M, Thibault C, Morissette M, Landry M, Di Paolo T (2001c). Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology 25: 242-257.
19. Daniel JM, Hulst JL, Lee CD (2005). Role of hippocampal M2 muscarinic receptors in the estrogen-induced enhancement of working memory. Neuroscience 132: 57-64.
20. Dhandapani KM, Brann DW (2003). Neuroprotective effects of estrogen and tamoxifen in vitro. Endocrine 21: 59-66.
21. Dohanich GP, Fader AJ, Javorsky DJ (1994). Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats. Behav Neurosci 108: 988-992.
22. Dumas J, Hancur-Bucci C, Naylor M, Sites C, Newhouse P (2008). Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Hormone Behav 53: 159-169.
23. Dumas JA, Hancur-Bucci C, Naylor M, Sites C, Newhouse PA (2006). Estrogen treatment effects on anticholinergic-induced cognitive dysfunction in normal post-menopausal women. Neuropsychopharmacology 31: 2065-2078.
24. Dumas JA, Kutz AM, Naylor MR, Johnson JV, Newhouse PA (2012). Estradiol reversal of anticholinergic-related brain activation in postmenopausal women. Neuroimage 60: 1394-1403.
25. Dumas JA, Newhouse PA (2011). The cholinergic hypothesis of cognitive aging revisited again: Cholinergic functional compensation. Pharmacol Biochem Behav 99: 254-261.
26. Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ (2004). Estrogen-and tamoxifen-associated effects on brain structure and function. Neuroimage 21: 364-371.
27. Ernst T, Chang L, Cooray D, Salvador C, Jovicich J, Walot I et al(2002). The effects of tamoxifen and estrogen on brain metabolism in elderly women. J Natl Cancer Inst 94: 592-597.
28. Esmaeili B, Basseda Z, Gholizadeh S, Javadi Paydar M, Dehpour AR (2009). Tamoxifen disrupts consolidation and retrieval of morphine-associated contextual memory in male mice: interaction with estradiol. Psychopharmacology (Berl) 204: 191-201.
29. Ewertz M, Mellemkjaer L, Poulsen AH, Friis S, Sorensen HT, Pedersen L et al(2005). Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer 92: 1293-1297.
30. Fader AJ, Johnson PEM, Dohanich GP (1999). Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine on a radial-arm maze. Pharmacol Biochem Behav 62: 711-717.
31. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn 59: 60-70.
32. Fester L, Ribeiro-Gouveia V, Prange-Kiel J, von Schassen C, Bottner M, Jarry H et al(2006). Proliferation and apoptosis of hippocampal granule cells require local oestrogen synthesis. J Neurochem 97: 1136-1144.
33. First MB, R.L. S, Gibbon M, Williams JBW (2001). Structured Clinical Interview for DSM-IV-TR Axis I Disorders-Patient Edition, SCID-I/P, 2/2001 ednAmerican Psychiatric Press Inc: Washington, DC, USA.
34. Gibbs RB (1998). Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp Neurol 151: 289-302.
35. Gibbs RB (1999). Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition. Hormone Behav 36: 222-233.
36. Gibbs RB (2000). Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 101: 931-938.
37. Gibbs RB (2001). Estrogen enhancement of learning requires intact basal forebrain cholinergic neutrons. Soci Neurosci Abstr 31: 312.
38. Gibbs RB (2010). Estrogen therapy and cognition: a review of the cholinergic hypothesis. Endocrine Rev 31: 224-253.
39. Gonzalez-Burgos I, Rivera-Cervantes MC, Velazquez-Zamora DA, Feria-Velasco A, Garcia-Segura LM (2012). Selective estrogen receptor modulators regulate dendritic spine plasticity in the hippocampus of male rats. Neural Plast 2012: 309494.
40. Hammond R, Gibbs RB (2011). GPR30 is positioned to mediate estrogen effects on basal forebrain cholinergic neurons and cognitive performance. Brain Res 1379: 53-60.
41. Hao J, Rapp PR, Leffler AE, Leffler SR, Janssen WGM, Lou W et al(2006). Estrogen alters spine number and morphology in prefrontal cortex of aged female rhesus monkeys. Jf Neurosci 26: 2571-2578.
42. Hazell GGJ, Yao ST, Roper JA, Prossnitz ER, O'Carroll A-M, Lolait SJ (2009). Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues. J Endocrinol 202: 223-236.
43. Hindmarch I (1984). Psychological performance models as indicators of the effects of hypnotic drugs on sleep. Psycho-pharmacology S1: 58-68.
44. Hoddes ElZ V, Smythe H, Phillips R, Dement W (1973). Quantification of sleepiness: a new approach. Psychophysiology 10: 431-436.
45. Hulley S, Grady D (2004). The WHI estrogen-alone trial-do things look any better? J Am Med Assocn 291: 1769-1771.
46. Ignatov A, Ignatov T, Roessner A, Costa S, Kalinski T (2010). Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells. Breast Cancer Res Treat 123: 87-96.
47. Kang JH, Grodstein F (2012). Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging 33: 1129-1137.
48. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ et al(2004). Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors a and b. Mol Biol Cell 15: 1262-1272.
49. Kristensen B, Ejlertsen B, Dalgaard P, Larsen L, Holmegaard SN, Transbol I et al(1994). Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study. J Clin Oncol 12: 992-997.
50. Lagunas N, Calmarza-Font I, Grassi D, Garcia-Segura LM (2011). Estrogen receptor ligands counteract cognitive deficits caused by androgen deprivation in male rats. Hormone Behav 59: 581-584.
51. Legault C, Maki PM, Resnick SM, Coker L, Hogan P, Bevers TB et al(2009). Effects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene. J Clin Oncol 27: 5144-5152.
52. Li X, Takahashi M, Kushida K, Koyama S, Hoshino H, Kawana K et al(1996). The effect of tamoxifen on bone metabolism and skeletal growth is different in ovariectomized and intact rats. Calc Tissue Int 59: 271-276.
53. Liu F, Day M, Muniz LC, Bitran D, Arias R, Revilla-Sanchez R et al(2008). Activation of estrogen receptor-[beta] regulates hippo-campal synaptic plasticity and improves memory. Nat Neurosci 11: 334-343.
54. Maggiolini M, Picard D (2010). The unfolding stories of GPR30, a new membrane-bound estrogen receptor. J Endocrinol 204: 105-114.
55. Maki PM (2005). A systematic review of clinical trials of hormone therapy on cognitive function: effects of age at initiation and progestin use. Ann NY Acad Sci 1052: 182-197.
56. Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J et al(2007). Estrogen therapy and coronary-artery calcification. N Engl J Med 356: 2591-2602.
57. McInerney EM, Weis KE, Sun J, Mosselman S, Katzenellenbogen BS (1998). Transcription activation by the human estrogen receptor subtypeb (ERb) studied with ERb and ERa receptor chimeras. Endocrinology 139: 4513-4522.
58. McMillan PJ, LeMaster AM, Dorsa DM (2002). Tamoxifen enhances choline acetyltransferase mRNA expression in rat basal forebrain cholinergic neurons. Mol Brain Res 103: 140-145.
59. McNair DM, Lorr M, Droppleman LF (1971). Profile of Mood States. Educational and Industrial Testing Service: San Diego, CA, USA.
60. Moreira PI, Custodio JB, Oliveira CR, Santos MS (2005). Brain mitochondrial injury induced by oxidative stress-related events is prevented by tamoxifen. Neuropharmacology 48: 435-447.
61. Mortensen EL, H0gh P (2001). A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57: 89-95.
62. Newhouse P, Newhouse C, Astur RS (2007). Sex differences in visual-spatial learning using a virtual water maze in pre-pubertal children. Behav Brain Res 183: 1-7.
63. Newhouse PA, Potter A, Corwin J, Lenox R (1994). Age-related effects of the nicotinic antagonist mecamylamine on cognition and behavior. Neuropsychopharmacology 10: 93-107.
64. Norbury R, Travis MJ, Erlandsson K, Waddington W, Ell PJ, Murphy DGM (2007). Estrogen therapy and brain muscarinic receptor density in healthy females: A SPET study. Hormone Behav 51: 249-257.
65. Obata T, Kubota S (2001). Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum. Neurosci Lett 308: 87-90.
66. Osborne CK (1998). Tamoxifen in the treatment of breast cancer. N Engl J Med 339: 1609-1618.
67. Overall J, Gorham D (1993). The brief psychiatric rating scale. Psycholo Rep 10: 799-812.
68. Paganini-Hill A, Clark LJ (2000). Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen. Breast Cancer Res Treat 64: 165-176.
69. Palmer JL, Trotter T, Joy AA, Carlson LE (2008). Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv 2: 275-282.
70. Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D et al(1995). Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA 92: 12260-12264.
71. Powles TJ (2012). Extended adjuvant tamoxifen for breast cancer-a new era? Lancet 381: 782-783.
72. Powles TJ, Hickish T, Kanis JA, Tidy A, Ashley S (1996). Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women. J Clin Oncol 14: 78-84.
73. Rossouw JE, Anderson GLInvestigators WGftWsHI (2002). Risks and benefits of estrogen plus progestin in healthy postmenpausal women. J Am Med Assoc 288: 321-331.
74. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM et al(2007). Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. J Am Med Assoc 297: 1465-1477.
75. Sharma K, Mehra RD (2008). Long-term administration of estrogen or tamoxifen to ovariectomized rats affords neuroprotection to hippocampal neurons by modulating the expression of Bcl-2 and Bax. Brain Res 1204: 1-15.
76. Sherwin BB (2007). The critical period hypothesis: can it explain discrepancies in the oestrogen-cognition literature. J Neuroendocrinol 19: 88-81.
77. Shughrue PJ, Scrimo PJ, Merchenthaler I (2000). Estrogen binding and estrogen receptor characterization (ERa and ERb) in the cholinergic neurons of the rat basal forebrain. Neuroscience 96: 41-49.
78. Silva I, LEAM Mello, Freymuller E, Haidar MA, Baracat EC (2000). Estrogen, progestogen and tamoxifen increase synaptic density of the hippocampus of ovariectomized rats. Neurosci Lett 291: 183-186.
79. Singh M, Meyer EM, Millard WJ, Simpkins JW (1994). Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 644: 305-312.
80. Tanabe F, Miyasaka N, Kubota T, Aso T (2004). Estrogen and progesterone improve scopolamine-induced impairment of spatial memory. J Med Dental Sci 51: 89-98.
81. Tinkler GP, Voytko ML (2005). Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog Neuro-Psychopharmacol Biol Psychiatr 29: 423-431.
82. Vehmanen L, Elomaa I, Blomqvist C, Saarto T (2006). Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol 24: 675-680.
83. Velazquez-Zamora DA, Garcia-Segura LM, Gonzalez-Burgos I (2012). Effects of selective estrogen receptor modulators on allocentric working memory performance and on dendritic spines in medial prefrontal cortex pyramidal neurons of ovariectomized rats. Hormones Behav 61: 512-517.
84. Wakade C, Khan MM, De Sevilla LM, Zhang Q-G, Mahesh VB, Brann DW (2008). Tamoxifen neuroprotection in cerebral ischemia involves attenuation of kinase activation and super-oxide production and potentiation of mitochondrial superoxide dismutase. Endocrinology 149: 367-379.
85. Wang JM, Irwin RW, Brinton RD (2006). Activation of estrogen receptor a increases and estrogen receptor b decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci USA 103: 16983-16988.
86. Ward HW (1973). Anti-oestrogen therapy for breast cancer: a trial of tamoxifen at two dose levels. Br Med J 1: 13-14.
87. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A et al(2003). Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women. J Am Med Assoc 289: 2673-2684.
88. Weber M, Mapstone M (2009). Memory complaints and memory performance in the menopausal transition. Menopause 16: 1-7.
89. Woolley CS, McEwen BS (1993). Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Compar Neurol 336: 293-306.
90. Wu X, Glinn MA, Ostrowski NL, Su Y, Ni B, Cole HW et al(1999). Raloxifene and estradiol benzoate both fully restore hippo-campal choline acetyltransferase activity in ovariectomized rats. Brain Res 847: 98-104.
91. Yaffe KM, Haan MD, Byers AM, Tangen CD, Kuller LMDD (2000). Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54: 1949-1954.
92. Yamamoto H, Kitawaki J, Kikuchi N, Okubo T, Iwasa K, Kawata M et al(2007). Effects of estrogens on cholinergic neurons in the rat basal nucleus. J Steroid Biochem Mol Biol 107: 70-79.
93. Yankova M, Hart SA, Woolley CS (2001). Estrogen increases synaptic connectivity between single presynaptic inputs and multiple postsynaptic CA1 pyramidal cells: a serial electron-microscopic study. Proc Natl Acad Sci USA 98: 2941-3624.